Evan Flowers is a partner who focuses his practice on white collar defense and investigations. For over a decade, Mr. Flowers has represented many of the world's most prominent companies and individuals in the following sectors: financial markets & services, pharmaceuticals, transport (aviation and automotive) and defence, energy and resources, construction, consumer goods (manufacturing and retail), gaming and casinos and technology, outsourcing and government procurement. He was named as a white collar “Rising Star” by Euromoney in its 2021 Expert Guide, based on his outstanding reputation among clients and industry leaders.  

Mr. Flowers advises multinationals on harm minimisation strategies for high risk commercial transactions and strategic investments, including M&A activity and corporate restructurings across all continents. He regularly engages with regulatory and prosecuting authorities in a variety of jurisdictions, including the UK Serious Fraud Office (SFO), Financial Conduct Authority (FCA), Competition & Markets Authority (CMA), European Commission (EC), US Department of Justice (DoJ), Securities Exchange Commission (SEC), Commodities Futures Trading Commission (CFTC) and regulated exchanges (CME, ICE, EEX).

Mr. Flowers also has experience in anti-bribery compliance, AML, securities fraud, insider trading, antitrust and cartel investigations, including cases giving rise to individual criminal liability in multiple jurisdictions.

Prior to joining Dechert, Mr. Flowers served as an associate in the white collar defense and investigations practice of another international law firm.

    • Airbus SE in a global investigation into allegations of fraud, bribery and corruption, and subsequent coordinated settlements with the UK Serious Fraud Office, French Parquet National Financier, U.S. Department of Justice and U.S. Department of State.
    • Aer Lingus in a successful defence of Ryanair’s hostile takeover bids and related UK Competition Commission investigation into Ryanair’s minority shareholding in Aer Lingus. 
    • A major US pharmaceutical company in various internal investigations into sales practices in Russia, Europe and Asia.
    • A US technology & outsourcing company with 100,000 employees in a major SEC accounting and securities fraud investigation.
    • Successfully defended individual employees of a major automotive manufacturer in hearings before German prosecutors.
    • A major European investment bank in an internal investigation resulting in a self- report to multiple UK authorities.